MAPS Partners with Psychedelic Therapy Alliance to Standardize…

Event summary

MAPS and the International Alliance of Psychedelic Therapy Practitioners announced a partnership on October 5, 2026 to advance training for psychedelic-assisted therapy.
The collaboration aims to strengthen professional education, develop clinical and ethical standards, and build infrastructure for the growing field.
The partnership will prioritize practitioner skill development through comprehensive training, clinical consultation, and continuing education.
The Psychedelic Therapy Alliance, formed in 2023, includes leading experts in the inner-directed therapy model used in clinical trials.

The big picture

The partnership between MAPS and the Psychedelic Therapy Alliance comes at a critical juncture as psychedelic-assisted therapy gains traction in healthcare systems. With the field rapidly evolving, the collaboration aims to build a sustainable workforce by combining decades of clinical expertise with structured training programs. This move is part of a broader trend towards professionalizing psychedelic therapy, ensuring that practitioners are well-equipped to deliver evidence-informed care.

What we're watching

Training Scalability: Whether MAPS and the Psychedelic Therapy Alliance can sustainably scale training programs to meet growing demand for psychedelic-assisted therapy practitioners.
Regulatory Alignment: How the partnership will navigate varying regulatory landscapes to ensure training standards are recognized internationally.
Ethical Standards: The pace at which the alliance can establish and enforce ethical guidelines to maintain the integrity of psychedelic-assisted therapy.